|
EP3601296A1
|
|
2-oxo-thiazole derivatives as a2a inhibitors and compounds for use in the treatment of cancers
|
|
WO2018178338A1
|
|
2-oxo-thiazole derivatives as a2a inhibitors and compounds for use in the treatment of cancers
|
|
ZA201607127B
|
|
Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors
|
|
CA2948842A1
|
|
Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors
|
|
CA2942761A1
|
|
Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use
|
|
US2015266857A1
|
|
Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use
|
|
EP3105225A1
|
|
Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
|
|
US2016263087A1
|
|
Novel 4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for use
|
|
EP3066090A1
|
|
4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for use
|
|
US2015133422A1
|
|
4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for use
|
